Membership: Join my YouTube channel membership and unlock exclusive perks! As a member, you'll get early access to videos to stay ahead with the latest content before anyone else. Investor tier members get access to my spreadsheets, and VIP discord members get access to our private discord community
1 extracted signal · 0 resolved · 1 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 14 Dec 2025, 03:16 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
AI-generated source summary
The analysis indicates a buying opportunity for Procter & Gamble (PG) with a long-term outlook extending to 2026 and beyond. The current market price is cited at $139.50, whereas the calculated intrinsic value per share is $177.52, suggesting a significant undervaluation. This assessment considers various factors, including the company's recent stock decline attributed to increased tariffs and higher costs of goods sold due to international manufacturing dependencies. Despite these headwinds, P&G demonstrates strong profitability, with a Return on Invested Capital (ROIC) of 15.2%, which is an improvement from 9.1% in 2016 and well above the company’s Weighted Average Cost of Capital. Furthermore, valuation multiples such as the forward Price-to-Earnings (P/E) at 19.7 and forward Price-to-Operating Cash Flow (P/OCF) at 16.8 are at their lowest levels since January 2024, reinforcing the undervaluation thesis. Even after incorporating an increased risk factor in the Discounted Cash Flow (DCF) model by adjusting the beta by 25% to account for current challenges, the stock retains its undervalued status. The analysis concludes with a bullish prediction for the asset, recommending it as a long-term investment.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.